S&P 500   4,566.88 (+0.26%)
DOW   35,469.47 (+0.15%)
QQQ   391.61 (+0.36%)
AAPL   190.90 (+0.26%)
MSFT   379.34 (-0.88%)
META   333.04 (-1.76%)
GOOGL   136.32 (-0.64%)
AMZN   146.60 (-0.29%)
TSLA   251.33 (+1.87%)
NVDA   482.59 (+0.92%)
NIO   7.32 (+1.53%)
BABA   75.20 (-2.01%)
AMD   124.93 (+2.39%)
T   16.21 (+0.19%)
F   10.75 (+3.66%)
MU   78.00 (+2.47%)
CGC   0.55 (+1.31%)
GE   118.90 (+0.04%)
DIS   91.45 (-1.14%)
AMC   7.09 (+5.82%)
PFE   30.08 (+1.31%)
PYPL   59.01 (+0.92%)
XOM   103.13 (-0.74%)
S&P 500   4,566.88 (+0.26%)
DOW   35,469.47 (+0.15%)
QQQ   391.61 (+0.36%)
AAPL   190.90 (+0.26%)
MSFT   379.34 (-0.88%)
META   333.04 (-1.76%)
GOOGL   136.32 (-0.64%)
AMZN   146.60 (-0.29%)
TSLA   251.33 (+1.87%)
NVDA   482.59 (+0.92%)
NIO   7.32 (+1.53%)
BABA   75.20 (-2.01%)
AMD   124.93 (+2.39%)
T   16.21 (+0.19%)
F   10.75 (+3.66%)
MU   78.00 (+2.47%)
CGC   0.55 (+1.31%)
GE   118.90 (+0.04%)
DIS   91.45 (-1.14%)
AMC   7.09 (+5.82%)
PFE   30.08 (+1.31%)
PYPL   59.01 (+0.92%)
XOM   103.13 (-0.74%)
S&P 500   4,566.88 (+0.26%)
DOW   35,469.47 (+0.15%)
QQQ   391.61 (+0.36%)
AAPL   190.90 (+0.26%)
MSFT   379.34 (-0.88%)
META   333.04 (-1.76%)
GOOGL   136.32 (-0.64%)
AMZN   146.60 (-0.29%)
TSLA   251.33 (+1.87%)
NVDA   482.59 (+0.92%)
NIO   7.32 (+1.53%)
BABA   75.20 (-2.01%)
AMD   124.93 (+2.39%)
T   16.21 (+0.19%)
F   10.75 (+3.66%)
MU   78.00 (+2.47%)
CGC   0.55 (+1.31%)
GE   118.90 (+0.04%)
DIS   91.45 (-1.14%)
AMC   7.09 (+5.82%)
PFE   30.08 (+1.31%)
PYPL   59.01 (+0.92%)
XOM   103.13 (-0.74%)
S&P 500   4,566.88 (+0.26%)
DOW   35,469.47 (+0.15%)
QQQ   391.61 (+0.36%)
AAPL   190.90 (+0.26%)
MSFT   379.34 (-0.88%)
META   333.04 (-1.76%)
GOOGL   136.32 (-0.64%)
AMZN   146.60 (-0.29%)
TSLA   251.33 (+1.87%)
NVDA   482.59 (+0.92%)
NIO   7.32 (+1.53%)
BABA   75.20 (-2.01%)
AMD   124.93 (+2.39%)
T   16.21 (+0.19%)
F   10.75 (+3.66%)
MU   78.00 (+2.47%)
CGC   0.55 (+1.31%)
GE   118.90 (+0.04%)
DIS   91.45 (-1.14%)
AMC   7.09 (+5.82%)
PFE   30.08 (+1.31%)
PYPL   59.01 (+0.92%)
XOM   103.13 (-0.74%)

Vir Biotechnology (VIR) Earnings Date, Estimates & Call Transcripts

$9.94
+0.34 (+3.54%)
(As of 10:33 AM ET)
Compare
Today's Range
$9.72
▼
$10.01
50-Day Range
$7.76
▼
$9.86
52-Week Range
$7.72
▼
$31.55
Volume
77,212 shs
Average Volume
1.16 million shs
Market Capitalization
$1.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.33
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Feb. 22Estimated
Actual EPS
(Nov. 2)
-$1.22 Missed By -$0.01
Consensus EPS
(Nov. 2)
-$1.21
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

VIR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VIR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vir Biotechnology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.88)($0.88)($0.88)
Q2 20232($1.32)($1.25)($1.29)
Q3 20232($1.43)($1.28)($1.36)
Q4 20232($0.98)$1.01$0.02
FY 20237($4.61)($2.40)($3.51)

VIR Earnings Date and Information

Vir Biotechnology last posted its quarterly earnings results on November 2nd, 2023. The reported ($1.22) EPS for the quarter, missing the consensus estimate of ($1.21) by $0.01. The business had revenue of $2.64 million for the quarter, compared to analysts' expectations of $12.57 million. Vir Biotechnology has generated ($4.49) earnings per share over the last year (($4.49) diluted earnings per share). Earnings for Vir Biotechnology are expected to remain at ($4.76) per share in the coming year. Vir Biotechnology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off prior year's report dates.

Vir Biotechnology Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/22/2024
Estimated)		------- 
11/2/2023Q3 2023($1.21)($1.22)($0.01)($1.22)$12.57 million$2.64 million
8/3/2023Q2 2023($1.21)($1.45)($0.24)($1.45)$22.39 million$3.80 million    
5/4/2023Q1 2023($0.86)($1.06)($0.20)($1.06)$50.10 million$63.00 million
2/23/2023Q4 2022($0.04)($0.76)($0.72)($0.76)$134.24 million$49.40 million
11/3/2022Q3 2022$0.01$1.30+$1.29$1.30$153.79 million$374.56 million
8/9/2022Q2 2022($0.17)($0.58)($0.41)($0.58)$211.14 million$40.60 million
5/5/2022Q1 2022$3.21$3.85+$0.64$3.85$811.05 million$1.20 billion    
2/24/2022Q4 2021$2.60$3.92+$1.32$3.92$622.90 million$812.75 million    
11/4/2021Q3 2021($0.30)$0.82+$1.12$0.82$138.25 million$103.62 million
8/5/2021Q2 2021($0.68)$0.46+$1.14$0.46$57.88 million$177.07 million  
5/6/2021Q1 2021($0.23)($1.32)($1.09)($1.32)$170.53 million$1.98 million  
2/24/2021Q4 2020($0.70)($0.83)($0.13)($0.83)$2.65 million$1.73 million












Vir Biotechnology Earnings - Frequently Asked Questions

When is Vir Biotechnology's earnings date?

Vir Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off last year's report dates. Learn more on VIR's earnings history.

Did Vir Biotechnology beat their earnings estimates last quarter?

In the previous quarter, Vir Biotechnology (NASDAQ:VIR) missed the analysts' consensus estimate of ($1.21) by $0.01 with a reported earnings per share (EPS) of ($1.22). Learn more on analysts' earnings estimate vs. VIR's actual earnings.

How much revenue does Vir Biotechnology generate each year?

Vir Biotechnology (NASDAQ:VIR) has a recorded annual revenue of $1.62 billion.

How much profit does Vir Biotechnology generate each year?

Vir Biotechnology (NASDAQ:VIR) has a recorded net income of $515.84 million. VIR has generated -$4.49 earnings per share over the last four quarters.

What is Vir Biotechnology's EPS forecast for next year?

Vir Biotechnology's earnings are expected to stay at ($4.76) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:VIR) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -